Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review | Synapse

January 12, 2009Open Access

Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

SF-36 measurements sometimes produce different results from those of the primary efficacy outcomes but rarely modify the overall interpretation of randomised trials. Quality of life and health related survey information should be utilised more systematically in randomised trials.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Contopoulos‐Ioannidis et al. (Mon,) studied this question.

synapsesocial.com/papers/69909c28c4a7da264f9e9af8 https://doi.org/https://doi.org/10.1136/bmj.a3006

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Users' guides to the medical literature1993 · 2,981 citations
2FDA draft guidance and health-outcomes research2007 · 80 citations
3Users' guides to the medical literature. XII. How to use articles about health-related quality of life. Evidence-Based Medicine Working Group1997 · 279 citations
4Users' Guides to the Medical Literature1997 · 290 citations
5The relationship between quality of research and citation frequency2006 · 184 citations